Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. [Phase 3]
Phase 3 clinical trial evaluating Lumateperone (Caplyta) to improve apathy in patients with psychotic symptoms, currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Critical Time Intervention-Peer Support [NA]
Clinical trial update indicates that the Critical Time Intervention-Peer Support study sponsored by the Lisbon Institute of Global Mental He…
-
FDA approval · 2024-06-26FDA Approved: OLANZAPINE — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for olanzapine from American Regent, Inc. for the generic product; the notice indicates a supplement…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia [Phase 3]
This update reports the completion of a Phase 3 trial evaluating the efficacy and safety of an investigational drug in acutely psychotic peo…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia [Phase 1]
This Phase 1 study assessed the safety, tolerability, and pharmacokinetics of SEP-363856 in male and female subjects with schizophrenia, and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia [Phase 1]
This completed Phase 1 trial evaluated the impact of SEP-363856 versus prior antipsychotic standard of care on body-weight–related parameter…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia [Phase 1]
Phase 1 clinical study evaluating the effect of SEP-363856 and prior antipsychotic standard of care on glucose and insulin regulation in sch…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of an investigational drug for schizophrenia in acutely psychotic patients has c…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia [Phase 1]
Phase 1 clinical trial update assessing whether SEP-363856 has physical dependence potential in adults with schizophrenia; the study has com…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard [Phase 1]
Phase 1 clinical trial update reporting a completed study that assessed how food affects gastric emptying and blood glucose in individuals w…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics [Phase 1]
A Phase 1 clinical trial evaluating SEP-363856 in male and female volunteers with varying schizotypy characteristics has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia. [Phase 1]
A completed Phase 1 clinical trial evaluating the effect of an investigational drug on ECG intervals in adults with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. [Phase 1]
A Phase 1 pharmacokinetic study to determine the effect of the investigational drug SEP-363856 on the pharmacokinetics of metformin in peopl…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia [Phase 1]
This update reports the completed Phase 1 study assessing safety, tolerability, and pharmacokinetics of SEP-363856 in adults with schizophre…
-
FDA approval · 2024-06-26FDA Approved: PALIPERIDONE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original application for a generic paliperidone product.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient
Ongoing clinical trial recruiting to develop a digital monitoring model to assess the mental state of hospitalized patients with severe ment…
-
CLINICAL_TRIALS withdrawal · 2024-06-24Clinical Trial Update: An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms [NA]
The UCLA-sponsored open-label, single-arm trial of amisulpride for treatment-resistant schizophrenia and schizoaffective disorder has been w…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Cognitive and Balance Dual Task Training for People With Schizophrenia [NA]
This document reports a completed clinical trial evaluating cognitive and balance dual-task training for people with schizophrenia. The stud…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia [NA]
A completed clinical trial investigating whether simultaneous walking and cognitive-task training improves cognitive function in people with…
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical Activity [NA]
This entry reports the completion of a trial evaluating an Acceptance and Commitment Therapy-based lifestyle counseling program to increase …
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study [NA]
A pilot clinical trial investigating the effects of high-definition transcranial alternating current stimulation (Hi-tACS) on cognitive func…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs [NA]
Completed clinical trial examining how cognitive and metacognitive performance influences knowledge learning during therapeutic education pr…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Efficacy of an Online-Based Self-Help Intervention for Auditory Hallucinations in Persons With Psychotic Disorders [NA]
This clinical trial update describes an online self-help intervention aimed at reducing auditory hallucinations in individuals with psychoti…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II) [Phase 2]
Phase 2 GRATITUDE II trial evaluating miricorilant for antipsychotic-induced weight gain in obese adults with schizophrenia; results have be…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in Schizophrenia [NA]
Terminated clinical trial examining the effects of transcranial direct current stimulation on cognitive control mechanisms in schizophrenia;…